Literature DB >> 3494745

Influence of growth medium and supplement on growth of Haemophilus influenzae and on antibacterial activity of several antibiotics.

M G Bergeron, P Simard, P Provencher.   

Abstract

In the present study, five non-beta-lactamase- and five beta-lactamase-producing strains of Haemophilus influenzae were used to determine whether three different growth media, Mueller-Hinton broth and agar, brain heart infusion broth and agar, and tryptic soy broth and agar, and their added supplements (0.2% hemin-0.1% IsoVitaleX, 1% hemin-1% IsoVitaleX, 2% sheep blood, 10% Fildes enrichment, 5% Fildes enrichment, 1% supplement B, 5% horse erythrocytes, and 2% hemoglobin-1% IsoVitaleX) would influence the growth rate of this microorganism and the antibacterial activity of eight antibiotics, including ampicillin, tetracycline, chloramphenicol, gentamicin, cefamandole, erythromycin, trimethoprim-sulfamethoxazole (TMP-SMX), and cefoperazone. The growth curve studies were carried out with an initial inoculum of 10(4) bacteria per ml, and MICs were determined with an inoculum of 5 X 10(5) microorganisms. Mueller-Hinton broth, brain heart infusion broth, and tryptic soy broth enriched with 5% Fildes resulted in a maximal growth of more than 10(8) CFU/ml at 24 h. When 10% Fildes or 2% sheep blood was added as enrichment to Mueller-Hinton broth, a considerable reduction in the growth rate of H. influenzae strains resulted (P less than 0.01). Significant variations in MICs (P less than 0.01) were observed with chloramphenicol, TMP-SMX, erythromycin, and cefoperazone when brain heart infusion agar, Mueller-Hinton agar, or tryptic soy agar was used. Chloramphenicol, gentamicin, erythromycin, and TMP-SMX were all affected by the different enrichments added to Mueller-Hinton agar. MICs were in general higher with 5% Fildes enrichment and lower with 1% supplement B. Cefoperazone was the only drug which exhibited a lower MIC in 5% Fildes enrichment for ampicillin-resistant H. influenzae strains.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494745      PMCID: PMC266053          DOI: 10.1128/jcm.25.4.650-655.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  47 in total

1.  Susceptibility of Hemophilus influenzae, type b, to ampicillin at Los Angeles County/University of Southern California Medical Center. A reappraisal after ten years.

Authors:  G D Overturf; J Wilkins; J M Leedom; D Ivler; A W Mathies
Journal:  J Pediatr       Date:  1975-08       Impact factor: 4.406

2.  Hemophilus influenzae pericarditis associated with meningitis.

Authors:  Z Q Farooki; J G Henry; E W Green
Journal:  Clin Pediatr (Phila)       Date:  1974-07       Impact factor: 1.168

3.  The inhibition of Haemophilus influenzae by certain agar and peptone preparations.

Authors:  N M Evans; D D Smith
Journal:  J Med Microbiol       Date:  1974-05       Impact factor: 2.472

4.  Antimicrobial susceptibility of Hemophilus influenzae.

Authors:  S E McLinn; J D Nelson; K C Haltalin
Journal:  Pediatrics       Date:  1970-05       Impact factor: 7.124

5.  In vitro activity of clindamycin and other antimicrobials against gram-positive bacteria and Hemophilus influenzae.

Authors:  M I Marks
Journal:  Can Med Assoc J       Date:  1975-01-25       Impact factor: 8.262

6.  Rapid detection of ampicillin-resistant Haemophilus influenzae and their susceptibility to sixteen antibiotics.

Authors:  R B Kammer; D A Preston; J R Turner; L C Hawley
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

7.  Tolerance of Haemophilus influenzae to beta-lactam antibiotics.

Authors:  M G Bergeron; G Y Lavoie
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

8.  Simplified medium for ampicillin susceptibility testing of Haemophilus influenzae.

Authors:  J H Jorgensen; P M Jones
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

9.  Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin.

Authors:  A A Medeiros; T F O'Brien
Journal:  Lancet       Date:  1975-03-29       Impact factor: 79.321

10.  In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole.

Authors:  L A Kirven; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

View more
  15 in total

1.  In vitro activity of clarithromycin and its 14-hydroxy-metabolite against 203 strains of Haemophilus influenzae.

Authors:  M G Bergeron; M Bernier; J L'Ecuyer
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

Review 2.  In vitro susceptibility testing of Haemophilus influenzae: review of new National Committee for Clinical Laboratory Standards recommendations.

Authors:  G V Doern
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

Review 3.  In vitro simulation of in vivo conditions: physical state of the culture medium.

Authors:  V Lorian
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

Review 4.  Haemophilus influenzae: antibiotic susceptibility.

Authors:  C A Needham
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 5.  Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.

Authors:  G V Doern; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

6.  Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid.

Authors:  P C Fuchs; A L Barry
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

Review 7.  Antibiotic resistance in Haemophilus influenzae: mechanisms, clinical importance and consequences for therapy.

Authors:  R de Groot; G Dzoljic-Danilovic; B van Klingeren; W H Goessens; H J Neyens
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

8.  Broth microdilution testing of Haemophilus influenzae with haemophilus test medium versus lysed horse blood broth. Canadian Haemophilus Study Group.

Authors:  S R Scriver; D E Low; A E Simor; B Toye; A McGeer; R Jaeger
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

9.  Disk diffusion versus broth microdilution susceptibility testing of Haemophilus species and Moraxella catarrhalis using seven oral antimicrobial agents: application of updated susceptibility guidelines of the National Committee for Clinical Laboratory Standards.

Authors:  P C Kibsey; R P Rennie; J E Rushton
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

10.  Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.

Authors:  D R Nash; C Flanagan; L C Steele; R J Wallace
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.